Table 3.
Pts (1–18) (n° of Gtvs) |
Re-SBRT type | Ovlp2Gy (cc) |
Ovlp50% (cc) | Liver Volume I SBRT (cc) |
Liver Volume re-SBRT (cc) |
Re-SBRT GTV volume (cc) | I-SBRT total dose/ dose for fx (Gy) |
re-SBRT total dose/ dose for fx (Gy) |
Prescription isodoses | Re-SBRTGTVs coverage Dmean (Gy) |
BED10_dmean | Timing I- reSBRT (months) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 (2*) | 1 A | 873 | 0 | 1290 | 1285 | 8 | 24/8 | 24/8 | Target mean | 24 | 43 | 7 |
2 | 1 B | 917 | 7,6 | 1162 | 1021 | 19 | 50/10 | 40/8 | 80% | 50 | 99 | 16 |
3 | 1 A | 1305 | 0 | 1750 | 1630 | 5 | 35/7 | 35/7 | Target mean | 35 | 59 | 2 |
4 | 1 A | 205 | 0 | 1138 | 1096 | 12,7 | 40/8 | 50/10 | 80% | 47 | 87,7 | 2 |
5 | 1 B | 1053 | 65 | 1671 | 1672 | 16,7 | 50/10 | 16/4 | Target mean | 24 | 35 | 18 |
6 (2*) | 1 A | 488,5 | 0 | 1428 | 1321 | 10,8 | 50/10 | 40/8 | 80% | 47,7 | 88,5 | 5 |
7 | 2 | 27,8 | 0 | 1208 | 1106 | 2,2 | 50/10 | 50/10 | 80% | 59 | 123 | 11 |
8 (2°) | 1 A | 2098 | 0 | 1352 | 1346 | 1,9 | 40/8 | 50/10 | 80% | 57,3 | 116,4 | 3 |
2098 | 0 | 1352 | 1346 | 5,3 | 40/8 | 50/10 | 80% | 57,1 | 116 | |||
9 (2*) | 1 A | 602 | 0 | 1403 | 1349 | 3,6 | 50/10 | 40/8 | 80% | 50 | 99 | 2 |
10 | 2 | 0 | 0 | 1610 | 2009 | 9,1 | 50/10 | 50/10 | 80% | 58 | 120 | 5 |
11 | 2 | 0 | 0 | 1017 | 1017 | 2,2 | 40/8 | 40/8 | 80% | 46,25 | 83,25 | 3 |
12 | 1 B | 380 | 1 | 1128 | 1131 | 1,5 | 35/7 | 35/7 | 80% | 43,65 | 71,46 | 6 |
13 | 1 B | 962,4 | 2 | 1112,7 | 1266,9 | 1,7 | 50/10 | 50/10 | 80% | 64,62 | 133,36 | 18 |
14 | 1 A | 417 | 0 | 975 | 1029 | 1,8 | 50/10 | 35/7 | Target mean | 35,6 | 59,2 | 5 |
15 (2*) | 1 B | 1448 | 5 | 1619,9 | 1647 | 12,5 | 40/8 | 50/10 | 80% | 62,92 | 132,38 | 4 |
16 | 2 | 11 | 0 | 1219 | 1115 | 2,6 | 50/10 | 40/8 | 80% | 51 | 93,06 | 28 |
17 (2*) | 2 | 17,8 | 0 | 1127 | 967 | 3,1 | 50/10 | 50/10 | 80% | 50,6 | 100 | 12 |
18 (2°) | 1 B | 450 | 3 | 1198,4 | 1303 | 2 | 40/8 | 40/8 | 80% | 48,76 | 88,5 | 6 |
450 | 3 | 1198,4 | 1303 | 2,9 | 40/8 | 35/7 | 80% | 37,7 | 61,5 |
Table 3: * Two lesions treated as unique GTV sum with dose prescription to one PTV sum. °Two separated GTVs treated with two different dose prescription to PTVs or two different plans